Dx dialogues: exciting upcoming developments in the treatment of CKD
Nephrologist Sean Hashmi, MD, discusses EOS789 and the early data for pan-phosphate approaches in the treatment of CKD and hyperphosphatemia.
Up Next
Dx dialogues: transcellular and paracellular transport inhibitors for CKD and hyperphosphatemia
Dx dialogues: 4 considerations in identifying patients for novel therapies for CKD
Dx dialogues: new treatment advances & future treatments for COPD
Managing CKD with chronic kidney disease
Dx dialogues: emerging therapies for MASH
Dx dialogues: common and emerging treatments for CRSWNP
Dx dialogues: recent advances in urinary track infection treatment
Dx dialogues: cell replacement therapies for type 1 diabetes
The importance of sleep while living with chronic kidney disease
How continued monitoring of kidney failure will help
